Current challenges facing pediatric radiation oncology viewed through an economics lens

Edward C Halperin1

  • 1Department of Radiation Oncology, Pediatrics, and History, New York Medical College and the Touro College and University System, Valhalla, New York.

Pediatric Blood & Cancer
|September 29, 2020
PubMed

Insights

Pediatric radiation oncology faces challenges in training due to limited cases and the high cost of advanced technologies like proton radiation therapy (RT). Economic tools can analyze these issues, but consensus on proton RT remains elusive.

Area of Science:

  • Pediatric Oncology
  • Radiation Oncology
  • Health Economics

Background:

  • Pediatric radiation oncology confronts dual challenges: inadequate workforce training opportunities and escalating technology costs.
  • Limited incidence of childhood cancers restricts clinical training cases for radiation oncology (RT) trainees.
  • Proton RT is increasingly recommended for pediatric patients, raising significant cost concerns.

Purpose of the Study:

  • To analyze workforce education and technology cost issues in pediatric radiation oncology using economic principles.
  • To examine the implications of proton RT adoption in pediatric cancer care.

Main Methods:

  • Economic analysis of workforce supply and demand in pediatric radiation oncology.
  • Review of current literature and arguments regarding proton RT versus photon RT for pediatric patients.

Main Results:

  • A mismatch exists between the number of radiation oncology trainees and the limited availability of pediatric radiotherapy cases.
  • Proton RT is frequently recommended for pediatric cases, but its high cost presents a substantial barrier.
  • Debate continues regarding the benefits and drawbacks of proton RT, with no clear consensus.

Conclusions:

  • Economic tools are essential for understanding and addressing the educational and technological challenges in pediatric radiation oncology.
  • The high cost of proton RT requires careful consideration and further economic evaluation.
  • Further research and discussion are needed to establish a consensus on the optimal use of proton RT in pediatric cancer treatment.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
165
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
144
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
134
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.6K